MAPS Bulletin Autumn 1994 Vol. 05, No. 2 Building Towards Clinical Trials
Dr. Juan Sanchez-Ramos and Deborah Mash, Ph.D. have completed the first portion of their Phase 1 study of the physiological and psychological effects of ibogaine in human volunteers. They have administered very low doses of ibogaine to a small number of subjects and have submitted their data to the FDA for review. They expect to be permitted to continue their experiment using higher doses in another small group of subjects.